PEAK6
EW icon

PEAK6’s Edwards Lifesciences EW Stock Holding History

PEAK6’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.99M Sell
37,300
-2,100
-5% -$173K 0.01% 1167
2025
Q4 		$3.36M Sell
39,400
-21,200
-35% -$1.74M 0.01% 1148
2025
Q3 		$4.71M Buy
60,600
+25,300
+72% +$1.98M 0.01% 1062
2025
Q2 		$2.76M Sell
35,300
-77,000
-69% -$5.74M 0.01% 1265
2025
Q1 		$8.14M Buy
112,300
+2,400
+2% +$172K 0.02% 677
2024
Q4 		$8.14M Buy
+109,900
New +$7.69M 0.02% 662

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PEAK6's EW Position: Q1 2026 in Review

PEAK6 sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 751 shares — an estimated $61.9K sold.

PEAK6 first reported a position in EW in Q4 2024 and held it in 3 quarters. The position peaked at $1.56M in Q3 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • PEAK6 reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • PEAK6 sold 751 Edwards Lifesciences shares in Q1 2026, an estimated $61.9K.
  • PEAK6 first reported a position in Edwards Lifesciences in Q4 2024 and held it in 3 quarters.
  • PEAK6's Edwards Lifesciences position peaked at $1.56M in Q3 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.